Intelligence Β· Patent portfolio
Nektar Therapeutics UK Patents
Full USPTO pharma patent portfolio for Nektar Therapeutics UK β grant dates, expiration, and drug cross-links.
- Patents
- 423
- Expiring β€24m
- 24
Quick answer
Nektar Therapeutics UK has 423 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 24 expire within 24 months β use filters for patent-cliff planning.
-
US 8546493
Multi-armed, monofunctional, and hydrolytically stable derivatives of poly(ethylene glycol) and related polymers for modification of surfaces and molecules
granted -
US 8541608
Method for preparing a polymer conjugate
granted -
US 8536213
Oligomer-dantrolene conjugates and related compounds
granted -
US 8530492
Oligomer-protein tyrosine kinase inhibitor conjugates
granted -
US 8519102
Polymer Factor VIII moiety conjugates
granted -
US 8507653
Factor IX moiety-polymer conjugates having a releasable linkage
granted -
US 8497357
Degradable heterobifunctional poly(ethylene glycol) acrylates and gels and conjugates derived therefrom
granted -
US 8492503
Polymeric alpha-hydroxy aldehyde and ketone reagents and conjugation method
granted -
US 8492488
Stabilized polymeric thiol reagents
granted -
US 8470301
Particulate materials
granted -
US 8466276
Oligomer conjugates of heteropentacyclic nucleosides
granted -
US 8461295
Methods for preparing polymeric reagents and compositions of polymeric reagents
granted -
US 8454946
N-maleimidyl polymer derivatives
granted -
US 8450390
Methods for the formation of hydrogels using thiosulfonate compositions and uses thereof
granted -
US 8449872
Polymer conjugates of nesiritide peptides
granted -
US 8440623
Polymer stabilized neuropeptides
granted -
US 8440787
Hydroxyapatite-targeting multiarm polymers and conjugates made therefrom
granted -
US 8440687
Oligomer-opioid agonist conjugates
granted -
US 8440816
Branched polymers
granted -
US 8435504
Method for preparing water-soluble polymer derivatives bearing a terminal carboxylic acid
granted -
US 8435505
Pharmaceutical compositions and methods for delivering such compositions
granted -
US 8420068
Polymer-based compositions and conjugates of antimicrobial agents
granted -
US 8404222
Soluble, degradable poly(ethylene glycol) derivatives for controllable release of bound molecules into solution
granted -
US 8394365
Multi-arm polymer prodrugs
granted -
US 8389759
Oligomer-anticholinergic agent conjugates
granted -
US 8383380
Segmented polymers and their conjugates
granted -
US 8372422
Hydroxyapatite-targeting poly(ethylene glycol) and related polymers
granted -
US 8354477
Multi-armed, monofunctional, and hydrolytically stable derivatives of poly(ethylene glycol) and related polymers for modification of surfaces and molecules
granted -
US 8354549
Method for preparing a polymer conjugate
granted -
US 8349800
Von Willebrand factor- and factor VIII-polymer conjugates having a releasable linkage
granted -
US 8349307
Polymer conjugates of opioid antagonists
granted -
US 8338545
Multi-arm block copolymers as drug delivery vehicles
granted -
US 8329876
Thioester-terminated water soluble polymers and method of modifying the N-terminus of a polypeptide therewith
granted -
US 8323632
Multi-arm polypeptide-poly(ethylene glycol) block copolymers as drug delivery vehicles
granted -
US 8318145
Multi-arm polymer prodrugs
granted -
US 8309680
Segmented degradable polymers and conjugates made therefrom
granted -
US 8304511
Maleamic acid polymer derivatives and their bioconjugates
granted -
US 8299173
Method involving 1-benzotriazolyl carbonate esters of polymers
granted -
US 8293869
Polymer conjugates of GLP-1
granted -
US 8273833
Branched Polymers
granted -
US 8273330
Particulate materials
granted -
US 8273339
Polymer-based compositions and conjugates of antimicrobial agents
granted -
US 8268948
Polymeric reagents comprising a terminal vinylic group and conjugates formed therefrom
granted -
US 8263062
Multi-arm polymer prodrugs
granted -
US 8258324
Intermediates useful in the preparation of maleimide functionalized polymers
granted -
US 8252275
Conjugates having a degradable linkage and polymeric reagents useful in preparing such conjugates
granted -
US 8247536
Factor VIII compositions
granted -
US 8247598
Methods for the formation of hydrogels using thiosulfonate compositions and uses thereof
granted
Frequently asked questions
How many patents does Nektar Therapeutics UK have?
423 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Nektar Therapeutics UK patents expire?
24 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.
Where does this data come from?
USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.
Data attribution: Data sources Β· Patent directory